
- Pharmaceutical Commerce - March 2010
Eli Lilly suffers $75-million burglary of branded products stolen from a Connecticut warehouse
Company says affected lots will no longer be distributed
What appears to have been a very professional burglary of a Lilly warehouse in Enfield, CT, on March 14 sets a recent record for the size of the heist, reported to be $75 million. (Ironically, Lilly also suffered the next-highest recent robbery, of a $37-million truckload last May that was quickly recovered). Brandnames involved in the theft include Cymbalta, Prozac, Strattera, Symbyax, Zyprexa, Gemzar and Alimta. The latter two are oncology drugs; the others are psychoactive drugs for depression and other disorders, but are not known as commonly used by drug abusers.
According to press accounts and sources close to the investigation, an (assumed) crew chose a Saturday night (the DC is closed over the weekend), cut a hole in the roof, rappelled inside, disarmed the security system, and then loaded some 70 pallets of Lilly products into a vehicle or vehicles and made their getaway. This was not an opportunistic grab of an unattended trailer on a highway rest stop, or a stickup of a pharmacy delivery, two of the most common types of drug theft.
A Lilly
Pharmaceutical Commerce
"The Lilly break was the largest burglary of its kind within recent memory," says Chuck Forsaith, director of security at Purdue Pharma and head of an industry group, the Pharmaceutical Cargo Security Coalition. "As bad as it was we will ultimately learn from it and strengthen the physical security of all of our assets to guard against any future attempts at this type of criminal activity."
Articles in this issue
over 15 years ago
The Pill as OTC -- Access Versus Health Concernsover 15 years ago
Going Around the Brand 'Positioning Wheel' With Kantar Healthover 15 years ago
Spotlight on the EMD Serono Specialty Digest, 6th EditionNewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.